Alemtuzumab (MabCampath OR Campath) is a cancer treatment drug. This medication used to treat chronic lymphocytic leukemia and multiple sclerosis. In CLL has been used as both a first line and second line treatment. In MS it is generally only recommended if other treatments have not worked. It is given by injection into a vein. It is a treatment for chronic lymphocytic leukaemia (CLL). You may also have it as part of some clinical trials for CLL or lymphoma. Or you may have it as part of a stem cell transplant.
alemtuzumab systemic Brand names: Lemtrada, Campath Drug class(es): CD52 monoclonal antibodies Alemtuzumab systemic is used in the treatment of:
- Chronic Lymphocytic Leukemia
- Multiple Sclerosis
- Rheumatoid Arthritis
- Click on the image above for More Details!